Comparison of Growth Inhibition and Clonogenic Assays for Assessing Radiotherapy Responses in Breast Cancer Cell...

Area of Science:

• Radiation oncology
• Cancer cell biology
• In vitro assay development

Background:

• In vitro assays are crucial for optimizing radiotherapy strategies before in vivo or clinical studies.
• Current use of multiple assay types with unclear comparability complicates cross-study radio- }sensitvity analysis.
• Direct comparison of widely used radiosensitivity assays is needed to clarify their relationship.

Purpose of the Study:

• To directly compare clonogenic survival and growth inhibition assays for radiosensitivity measurement.
• To determine if these two common assays yield correlated or complementary data.
• To assess the repeatability of both assays in breast cancer cell lines.

Main Methods:

• Five breast cancer cell lines were subjected to X-ray irradiation (2, 4, 6, 8 Gy).
• Clonogenic survival and growth inhibition assays were performed using established protocols.
• Spearman correlations assessed assay measurement relationships; experiments were repeated for repeatability.

Main Results:

• No significant correlation was found between clonogenic and growth inhibition assay measurements at given radiation doses.
• The radiation dose for 50% growth inhibition (3.2 Gy) was significantly higher than for 50% survival (1.3 Gy).
• Growth inhibition assay showed a trend towards lower measurement variability (coefficient of variation) than clonogenic assay.

Conclusions:

• Clonogenic survival and growth inhibition assays provide complementary, not correlated, measures of cellular radiation response.
• Assay selection for radiotherapy studies requires careful consideration of the specific information each provides.
• Combining both assays may offer a more comprehensive characterization of cancer cell radiosensitivity.